Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm

  • Authors:
    • Katarzyna Oszajca
    • Konrad Wroński
    • Grażyna Janiszewska
    • Małgorzata Bieńkiewicz
    • Michał Panek
    • Jacek Bartkowiak
    • Janusz Szemraj
  • View Affiliations

  • Published online on: June 12, 2012     https://doi.org/10.3892/etm.2012.608
  • Pages: 514-518
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Increased activity of the coagulation system is associated with the increased risk of many arterial thrombotic diseases and atherosclerosis. The purpose of this study was to evaluate the influence of selected polymorphisms in genes coding for coagulation factor V (1691 G/A, the so-called Leiden mutation), factor VII (-323 0/10 bp insertion/deletion) and fibrinogen β chain (-455 G/A) on the risk of abdominal aortic aneurysm, a particular form of atherothrombosis. We conducted a case-control study of 153 Polish patients hospitalized due to abdominal aortic aneurysm (AAA) and compared the results to those obtained from matched healthy control subjects. The polymorphisms were ascertained through genotyping by polymerase chain reaction and restriction digestion of amplified fragments. The study revealed that individuals carrying heterozygous genotype GA for the fibrinogen β chain -455 G/A mutation had at least a 2-fold greater likelihood of AAA development compared to control subjects (OR=3.01; 95% CI 1.83-4.96). The cases possessing homozygous mutant genotype (AA) had no significant risk of developing AAA compared to the control subjects (OR=1.12; 95% CI 0.33-2.44; p=0.83). Concerning factor V 1691 G/A and factor VII -323 0/10 bp mutations, we did not find any statistically significant correlation between them and AAA occurrence. In conclusion, we suggest that the -455G/A polymorphism of the fibrinogen β chain gene is a potential genetic marker to identify the risk of AAA.
View References

Related Articles

Journal Cover

September 2012
Volume 4 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Oszajca K, Wroński K, Janiszewska G, Bieńkiewicz M, Panek M, Bartkowiak J and Szemraj J: Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm. Exp Ther Med 4: 514-518, 2012
APA
Oszajca, K., Wroński, K., Janiszewska, G., Bieńkiewicz, M., Panek, M., Bartkowiak, J., & Szemraj, J. (2012). Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm. Experimental and Therapeutic Medicine, 4, 514-518. https://doi.org/10.3892/etm.2012.608
MLA
Oszajca, K., Wroński, K., Janiszewska, G., Bieńkiewicz, M., Panek, M., Bartkowiak, J., Szemraj, J."Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm". Experimental and Therapeutic Medicine 4.3 (2012): 514-518.
Chicago
Oszajca, K., Wroński, K., Janiszewska, G., Bieńkiewicz, M., Panek, M., Bartkowiak, J., Szemraj, J."Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm". Experimental and Therapeutic Medicine 4, no. 3 (2012): 514-518. https://doi.org/10.3892/etm.2012.608